PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26780827-10	2016	Protein levels of COX-2 and mPGES-1 were reduced by SB203580, SP600125, and SC514 (p38 mitogen-activated protein kinase (MAPK), c-Jun N-terminal kinase (JNK), and IkappaB kinase (IKK) inhibitors, respectively), as well as by PD98059 and PD0325901 (mitogen-activated protein kinase kinase (MEK) inhibitors).	pyrazolanthrone	62-70	prostaglandin-endoperoxide synthase 2	Rattus norvegicus	18-23	
25010483-9	2014	Furthermore, EA and the JNK inhibitor SP600125 synergistically inhibited CFA-induced hyperalgesia and suppressed the COX-2 mRNA expression in the spinal dorsal horn.	pyrazolanthrone	38-46	prostaglandin-endoperoxide synthase 2	Rattus norvegicus	117-122	
22700825-7	2012	ERKs inhibitor PD98059, p38 inhibitor SB203580, and JNKs inhibitor SP600125 significantly blocked stretch-induced COX-2 expression.	pyrazolanthrone	67-75	prostaglandin-endoperoxide synthase 2	Rattus norvegicus	114-119	
16818793-9	2006	In addition, IL-13 potentiated LPS-induced activation of JNK, and the JNK inhibitor SP600125 suppressed the enhancement of COX-2 expression and attenuated microglial death.	pyrazolanthrone	84-92	prostaglandin-endoperoxide synthase 2	Rattus norvegicus	123-128